| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4764fd29d50c04f59362737d23e1d93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cff1c88da86d04c304232e50be699bd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e4c81c6917d66990f3215dcb1534f0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f7515bc35e14dd58e6427a470a9a6d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1e43b4681701d3112d863a66715b968 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-773
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-704 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
2009-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a17339557bae79b645afbd55ce549a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce245a3e78e811bdf92364ac8e7099b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe7b387d0efe4744d0c060d1f65ae0ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48439ad90d4f573f89f3ad9e8ce2aa7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b12dd3a234ae1395dbe3188201642614 |
| publicationDate |
2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011293671-A1 |
| titleOfInvention |
Bacteriophage compositions for treatment of bacterial infections |
| abstract |
A respirable composition for treatment of a bacterial infection includes one or more active bacteriophages in combination with a pharmaceutically acceptable respirable carrier. The composition includes a carbohydrate carrier, and is prepared as fine powder. In another aspect, bacteriophages are provided in a liquid carrier for administration by nebulization. In one aspect, the bacteriophages have anti-bacterial activity against one or more species or strains of Burkholderia cepacia complex (BCC) bacteria. The invention further relates to the use of a BCC bacteriophage to treat a BCC infection, in particular in an individual suffering from cystic fibrosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114703152-A |
| priorityDate |
2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |